Research Results Clinically tested for skin irritation on sensitive Skin Clinically tested for non-comedogenic After a single application, more than 85 % of the skin hydration lasted for up to 24 hours.* *Clinical testing in 20 people
PMID 39701638
44,45 In a meta-analysis of 48 RCTs including 27,729 participants, the overall incidence of GI adverse events was reported to be 11.6%, with nausea identified as the most common symptom (21.4%)
Andr-Lvigne D, Pignel R, Boet S, Jaquet V, Kalbermatten DF, Madduri S
Considering that two out of five adults are obese, various treatments are often employed to reduce fat and help bring down the scale
Retatrutide is not yet licensed in the UK, so all current evidence must be interpreted within the context of ongoing research rather than established clinical practice